Enterovirus 71 meningoencephalitis complicating rituximab therapy

Journal of the Neurological Sciences

Volumn 305, Issue 1-2, 2011, Pages 149-151

  Ahmed, Rebekah ^a   Buckland, Michael ^a   Davies, Leo ^a   Halmagyi, G Michael ^a   Rogers, Shannon L ^b   Oberste, Steven ^b   Barnett, Michael H ^a,c  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Encephalitis; Enterovirus 71; Monoclonal antibody; Rituximab

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PREDNISONE; RITUXIMAB; VIRUS RNA;

ADULT; ARTICLE; B LYMPHOCYTE; CASE REPORT; CEREBROSPINAL FLUID; ENTEROVIRUS 71; FEVER; GENE SEQUENCE; HEADACHE; HEMATOLOGIC DISEASE; HUMAN; INFLAMMATORY DISEASE; LIMB WEAKNESS; LYMPHOCYTE DEPLETION; MALE; MENINGOENCEPHALITIS; NONHODGKIN LYMPHOMA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEOCYTOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIGOR; THALAMUS; VIRAL CLEARANCE;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; ENTEROVIRUS A, HUMAN; ENTEROVIRUS INFECTIONS; FATAL OUTCOME; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MENINGOENCEPHALITIS; MIDDLE AGED;

EID: 79955683314     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2011.03.009     Document Type: Article

References (12)

1. Nix WA, Oberste MS, Pallansch MA. Seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. J Clin Microbiol 2006;44:2698-704. (Pubitemid 44228559)
2. Oberste MS, Pallansch MA. Enterovirus molecular detection and molecular typing. Rev Med Microbiol 2005;16:163-71.
3. Huang CC, Liu CC, Chang YC, Chen CY, Wang ST, Yeh TF. Neurologic complications in children with enterovirus 71 infection. NEJM 1999;341:936-42.
4. Leitch EC, Harvala H, Robertson I, Ubillos I, Tempelton K, Simmonds P. Direct identification of human enterovirus serotypes in cerebrospinal fluid by amplification and sequencing of the VP1 region. J Clin Virol 2009;44:119-24.
5. Van der Sanden S, Koopmans M, Uslu G, Van der Avoort H. Epidemiology of enterovirus 71 in the Netherlands, 1963 to 2008. J Clin Microbiol 2009;47:2826-33.
6. Perez-Velez CM, Anderson MS, Robinson CC, Mcfarland EJ, Nix WA, Pallansch MA, et al. Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge. Clin Infect Dis 2007;45:950-7.
7. Pescovitz MD. Rituximab, an anti-CD20 monoclonal antibody: history and mechanism of action. Am J Transplant 2006;6:859-66. (Pubitemid 44356635)
8. McLaughlin P, Grillo-Lopez A, Link BK, Czuczman MS, Williams ME, Heyman MR, Bence-Bucker I, White CA, Cabanillas F, Jain V, Ho AD, Lister J, Wey K, Shen D, Dallaire BK. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to four-dose treatment program. J Clin Oncol 1998;16:2825-33. (Pubitemid 28363048)
9. Quartier P, Tournilhac O, Archimbaud C, Lazaro L, Chaleteix C, Miller P, et al. Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatment. Clin Infect Dis 2003;36:47-9.
10. Padate BP, Keidan J. Enteroviralmeningoencephalitis in a patientwith non-Hodgkin's lymphoma treated previously with rituximab. Clin Lab Haem 2006;28:69-71.
11. Ganjoo KN, Raghan R, Sobel RA, Pinto H. Opportunistic enteroviral meningoencephalitis: an unusual treatable complication of rituximab therapy. Leuk Lymphoma 2009;50:673-5.
12. McMinn P. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 2002;26:91-107. (Pubitemid 34454778)